Rho Showcases History of Success and Expertise at 3rd Annual OCT Southeast Show

February 25, 2014

CHAPEL HILL, NC, UNITED STATES - Feb 25, 2014 - Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) Southeast conference, which is being held in Rho's backyard and what is considered the east coast biotech epicenter, better known as Research Triangle Park (RTP), March 4-5 in Cary, NC.                                  

With its 30th anniversary this year, Rho brings years of expertise to the OCT Southeast show- from thriving in the hotbed of the Triangle pharmaceutical industry to adapting to industry innovations over the last three decades.

Event attendees are invited to stop by Rho's booth (#18) to learn more about the services they provide to ensure an efficient and effective drug development process. Rho focuses on helping pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services. These services include clinical operations, project management, data management, data standards and biostatistics with extensive experience in many therapeutic areas.  Additionally, Rho will have several industry specialists available for interviews in advance of the show. 

 

WHO: Rho experts available for interview at OCT:

  • Braden Saunders, senior director, business development, Rho
  • KC Morris, director, business development, Rho

 

WHEN: March 4-5, 2014

 

WHERE:   Embassy Suites, Raleigh-Durham Research Triangle, 201 Harrison Oaks Blvd., Cary, N.C. 27513

 

DETAILS:  For media inquiries please contact Jessica Highsmith at Largemouth Communications, (919) 459-6456, jessica@largemouthpr.com.

 

ABOUT:  Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 30 years, Rho has been a trusted partner to some of the industry's leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.

###